Offer - Urjas Oil for just ₹ 1 X
Combiwave SF 25 Mcg/250 Mcg Inhaler is a commercial drug that is prescribed in the form of Inhaler. Secondary and off-label uses of Combiwave SF 25 Mcg/250 Mcg Inhaler have also been mentioned below.
The correct dosage of Combiwave SF 25 Mcg/250 Mcg Inhaler depends on the patient's age, gender, and medical history. The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
Combiwave SF 25 Mcg/250 Mcg Inhaler also has some side effects, the most common being Shortness of Breath, Throat Irritation, Nosebleed. Besides the aforementioned side effects, there are other adverse effects of Combiwave SF 25 Mcg/250 Mcg Inhaler as well, which are listed below. Such side effects of Combiwave SF 25 Mcg/250 Mcg Inhaler normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Combiwave SF 25 Mcg/250 Mcg Inhaler is Moderate for pregnant women and Mild for women who are breastfeeding. In addition, Combiwave SF 25 Mcg/250 Mcg Inhaler's effects on the liver, heart and kidney are discussed below in the Combiwave SF 25 Mcg/250 Mcg Inhaler related warnings section.
Other conditions have been mentioned below in the Combiwave SF 25 Mcg/250 Mcg Inhaler contraindications section.
Drug interactions for Combiwave SF 25 Mcg/250 Mcg Inhaler have been reported in the medical literature. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Combiwave SF 25 Mcg/250 Mcg Inhaler is considered safe while driving, and is addictive.
Combiwave SF 25 Mcg/250 Mcg Inhaler is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
13 - 18 years (Adolescent) |
|
Adult |
|
Geriatric |
|
Is the use of Combiwave SF 25 Mcg/250 Mcg Inhaler safe for pregnant women?
Combiwave SF can have harmful effects in pregnant women. If you experience any discomfort after using Combiwave SF, then discontinue the use and take your doctor's advice.
Is the use of Combiwave SF 25 Mcg/250 Mcg Inhaler safe during breastfeeding?
Combiwave SF may have very limited harmful effects for breastfeeding women.
What is the effect of Combiwave SF 25 Mcg/250 Mcg Inhaler on the Kidneys?
Combiwave SF is completely safe for kidneys.
What is the effect of Combiwave SF 25 Mcg/250 Mcg Inhaler on the Liver?
Combiwave SF may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Combiwave SF 25 Mcg/250 Mcg Inhaler on the Heart?
The heart can be affected by Combiwave SF. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
If you are suffering from any of the following diseases, you should not take Combiwave SF 25 Mcg/250 Mcg Inhaler unless your doctor advises you to do so -
Is this Combiwave SF 25 Mcg/250 Mcg Inhaler habit forming or addictive?
No, there is no any evidence that Combiwave SF 25 Mcg/250 Mcg Inhaler is addictive.
Interaction between Food and Combiwave SF 25 Mcg/250 Mcg Inhaler
There is no information on the effects of taking Combiwave SF 25 Mcg/250 Mcg Inhaler with food, because this topic has not been scientifically researched yet.
Interaction between Alcohol and Combiwave SF 25 Mcg/250 Mcg Inhaler
It is difficult to say anything about the effect of Combiwave SF 25 Mcg/250 Mcg Inhaler and alcohol. No research has been done on this yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Serevent Diskus (salmeterol xinafoate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 223-224
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1122-1123
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Flonase (fluticasone propionate)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 231
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 355-359